- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Tonix Pharmaceuticals Holding is a biotechnology business based in the US. Tonix Pharmaceuticals Holding shares (TNXP) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.14 – a decrease of 15.83% over the previous week. Tonix Pharmaceuticals Holding employs 103 staff and has a trailing 12-month revenue of around $12.5 million.
What's in this guide?
- TNXP shares summary
- Compare share dealing platforms
- Is TNXP stock a buy or sell?
- Stock performance over time
- Can I short TNXP shares?
- Tonix Pharmaceuticals Holding's financials
- How volatile are TNXP shares?
- Does Tonix Pharmaceuticals Holding pay a dividend?
- Have TNXP shares ever split?
- Other common questions
Our top picks for where to buy Tonix Pharmaceuticals Holding stock
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Tonix Pharmaceuticals Holding stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – TNXP. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Tonix Pharmaceuticals Holding stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Tonix Pharmaceuticals Holding stock price (NASDAQ: TNXP)
Use our graph to track the performance of TNXP stocks over time.Tonix Pharmaceuticals Holding shares at a glance
Information last updated 2024-10-28.
| Latest market close | $0.14 |
|---|---|
| 52-week range | $0.12 - $22.14 |
| 50-day moving average | $0.20 |
| 200-day moving average | $4.45 |
| Wall St. target price | $21.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-139.08 |
Is it a good time to buy Tonix Pharmaceuticals Holding stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Tonix Pharmaceuticals Holding price performance over time
Historical closes compared with the close of $0.1453 from 2024-10-31
| 1 week (2024-10-25) | -12.21% |
|---|---|
| 1 month (2024-10-03) | 15.32% |
| 3 months (2024-08-02) | -69.70% |
| 6 months (2024-05-03) | -20.82% |
| 1 year (2023-11-03) | -71.45% |
|---|---|
| 2 years (2022-11-03) | -68.41% |
| 3 years (2021-11-03) | 0.57 |
| 5 years (2019-11-01) | 3.61 |
Tonix Pharmaceuticals Holding financials
| Revenue TTM | $12.5 million |
|---|---|
| Gross profit TTM | $0 |
| Return on assets TTM | -51.72% |
| Return on equity TTM | -163.24% |
| Profit margin | 0% |
| Book value | $4.28 |
| Market Capitalization | $23.5 million |
TTM: trailing 12 months
Tonix Pharmaceuticals Holding share dividends
We're not expecting Tonix Pharmaceuticals Holding to pay a dividend over the next 12 months.
Have Tonix Pharmaceuticals Holding's shares ever split?
Tonix Pharmaceuticals Holding's shares were split on a 1:32 basis on 9 June 2024 . So if you had owned 32 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Tonix Pharmaceuticals Holding shares – just the quantity. However, indirectly, the new 3100% higher share price could have impacted the market appetite for Tonix Pharmaceuticals Holding shares which in turn could have impacted Tonix Pharmaceuticals Holding's share price.
Tonix Pharmaceuticals Holding share price volatility
Over the last 12 months, Tonix Pharmaceuticals Holding's shares have ranged in value from as little as $0.118 up to $22.1376. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tonix Pharmaceuticals Holding's is 2.087. This would suggest that Tonix Pharmaceuticals Holding's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Tonix Pharmaceuticals Holding overview
Tonix Pharmaceuticals Holding Corp. , a biopharmaceutical company, focuses on developing, discovering, commercializing, and licensing therapeutics to treat and prevent human disease and alleviate suffering. It markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. Its portfolio focuses on central nervous system disorders, as well as rare disease, immunology, and infectious disease product candidates. The company's priority is to submit a New Drug Application (NDA) to the FDA for TNX-102 SL (cyclobenzaprine HCl sublingual tablet), which has completed two positive Phase 3 studies for the management of fibromyalgia. TNX-102 SL is also being developed to treat fibromyalgia-type Long COVID, a chronic post-acute COVID-19 condition. Its TNX-1300 (cocaine esterase) is a biologic designed to treat cocaine intoxication and has been granted breakthrough therapy designation by the FDA.
Frequently asked questions
What percentage of Tonix Pharmaceuticals Holding is owned by insiders or institutions?Currently 0.211% of Tonix Pharmaceuticals Holding shares are held by insiders and 0.235% by institutions. How many people work for Tonix Pharmaceuticals Holding?
Latest data suggests 103 work at Tonix Pharmaceuticals Holding. When does the fiscal year end for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding's fiscal year ends in December. Where is Tonix Pharmaceuticals Holding based?
Tonix Pharmaceuticals Holding's address is: 26 Main Street, Chatham, NJ, United States, 07928 What is Tonix Pharmaceuticals Holding's ISIN number?
Tonix Pharmaceuticals Holding's international securities identification number is: US8902607063 What is Tonix Pharmaceuticals Holding's CUSIP number?
Tonix Pharmaceuticals Holding's Committee on Uniform Securities Identification Procedures number is: 890260102
More resources on Finder
More guides on Finder
-
How to buy Zentek stock (ZTEK)
Steps to owning and managing ZTEK, with 24-hour and historical pricing before you buy.
-
How to buy ATAI Life Sciences stock (Atai Life Sciences)
Steps to owning and managing ATAI, with 24-hour and historical pricing before you buy.
-
How to buy Seelos Therapeutics stock (SEEL)
Steps to owning and managing SEEL, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Humana stock (HUM)
Steps to owning and managing HUM, with 24-hour and historical pricing before you buy.
-
How to buy Illumina stock (ILMN)
Steps to owning and managing ILMN, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Moderna stock (MRNA)
Steps to owning and managing MRNA, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question